已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Distinct immune microenvironment of venous tumor thrombus in hepatocellular carcinoma at single-cell resolution

肝细胞癌 免疫系统 癌症研究 医学 肿瘤微环境 CD8型 转移 免疫学 内科学 癌症
作者
Kaiqian Zhou,Yucheng Zhong,Ming-Fang Song,Yun‐Fan Sun,Wei Zhu,Jianwen Cheng,Yang Xu,Zefan Zhang,Pengxiang Wang,Zheng Tang,Jian Zhou,Liye Zhang,Jia Fan,Xin‐Rong Yang
出处
期刊:Hepatology [Lippincott Williams & Wilkins]
标识
DOI:10.1097/hep.0000000000001182
摘要

Portal vein tumor thrombus (PVTT) worsens the prognosis of hepatocellular carcinoma by increasing intrahepatic dissemination and inducing portal vein hypertension. However, the immune characteristics of PVTT remain unclear. Therefore, this study aims to explore the immune microenvironment in PVTT. Time-of-flight mass cytometry (CyTOF) revealed that macrophages and monocytes were the dominant immune cell type in PVTT, with a higher proportion than in primary tumor (PT) and blood (54.1% vs. 26.3% and 9.1%, p<0.05). The differentially enriched clustering of inhibitory and regulatory immune cells in PVTT indicated an immune-suppressive environment. According to the single-cell RNA sequencing (scRNA-seq), TAM-C5AR1 was characterized by leukocyte chemotaxis and was the most common subpopulation in PVTT (36.7%). Multiple immunofluorescence staining showed that the C5aR+ TAM/Mφ were enriched in PVTT compared to both PT and liver, and positively correlated with C5a (r=0.559, p<0.001). Notably, THP-1 (monocyte cell line) was recruited by CSQT2 (PVTT cell line) and exhibited up-regulation of CD163, CD206, and PD-L1 upon stimulation. C5aR antagonist could reverse this. C5aR+ TAMs could also inhibit Granzyme B in CD8+ T cells. High infiltration of C5aR+ TAMs in PVTT correlated with poor differentiation (p<0.009), and was a risk factor for overall survival (p=0.003) and for re-formation of PVTT after resection (p=0.007). TAMs, especially C5aR+ TAMs, were enriched in PVTT. C5aR+ TAMs contribute to the development of PVTT and poor prognosis by reshaping the immunosuppressive environment.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
包子凯越完成签到,获得积分10
刚刚
1秒前
白鹭立雪完成签到,获得积分10
9秒前
念初发布了新的文献求助10
10秒前
搜集达人应助fu采纳,获得10
12秒前
13秒前
快乐的小叮当应助噗宝凹采纳,获得10
13秒前
充电宝应助Chi_bio采纳,获得10
13秒前
粥粥应助碧蓝的宝马采纳,获得10
13秒前
柚又完成签到 ,获得积分10
16秒前
小王顶呱呱完成签到 ,获得积分10
16秒前
18秒前
18秒前
可知发布了新的文献求助10
19秒前
19秒前
20秒前
rhei发布了新的文献求助20
21秒前
氯化氟完成签到 ,获得积分20
21秒前
zydong完成签到,获得积分10
22秒前
詹卫卫发布了新的文献求助10
23秒前
i3utter发布了新的文献求助10
24秒前
25秒前
深情安青应助AOPs采纳,获得10
25秒前
六年发布了新的文献求助30
26秒前
Dorr发布了新的文献求助10
26秒前
打打应助氯化氟采纳,获得10
27秒前
隐形曼青应助念初采纳,获得10
27秒前
一直向前发布了新的文献求助10
27秒前
丘比特应助rhei采纳,获得30
29秒前
orixero应助洛芷采纳,获得10
31秒前
32秒前
丘比特应助多年以后采纳,获得10
32秒前
zhongu发布了新的文献求助10
32秒前
恋雅颖月应助晶晶采纳,获得10
34秒前
xiaoming发布了新的文献求助200
34秒前
35秒前
洛芷完成签到,获得积分10
36秒前
Dorr完成签到,获得积分10
37秒前
37秒前
科研通AI5应助听听采纳,获得10
37秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
Aktuelle Entwicklungen in der linguistischen Forschung 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989918
求助须知:如何正确求助?哪些是违规求助? 3532013
关于积分的说明 11255831
捐赠科研通 3270829
什么是DOI,文献DOI怎么找? 1805053
邀请新用户注册赠送积分活动 882233
科研通“疑难数据库(出版商)”最低求助积分说明 809216